Dbott Biotec Private Limited
About Dbott Biotec Private Limited
Data last updated:
Dbott Biotec Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 21 September 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2012PTC242650. Its GSTIN is 10AAECD4209P1ZS (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Nirmal Kumar and Rajesh Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No – S – 124 Road No – 4 West Vinod Nagar, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.51 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹3.66 Lakh (net margin 1.5%) and EBITDA of ₹4.95 Lakh (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 5% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Dbott Biotec Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No – S – 124 Road No – 4 West Vinod Nagar, New Delhi, Delhi, India – 110092
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Dbott Biotec Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dbott Biotec is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dbott Biotec Private Limited, buy the company report.
Financials of Dbott Biotec Private Limited
FY 2025 filings availableDbott Biotec Private Limited reported revenue of ₹2.51 Cr (down 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 1% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.95 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.66 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dbott Biotec Private Limited, buy the company report.
Board of directors of Dbott Biotec Private Limited
Dbott Biotec has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nirmal Kumar | Director | 21 Sep 2012 | 14 Years 1 Months | Current |
| Rajesh Kumar Singh | Director | 21 Sep 2012 | 14 Years 1 Months | Current |
| Ranjay Kumar | Director | 20 Aug 2015 | 11 Years 2 Months | Current |
Auditor
Dbott Biotec Private Limited is audited by KESHAV CHANDRA AND CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KESHAV CHANDRA AND CO | FY 2017 | 016296C |
Shareholding
The shareholding of Dbott Biotec Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Dbott Biotec Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dbott Biotec Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dbott Biotec Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dbott Biotec has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAECD4209P1ZS | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dbott Biotec Private Limited, buy the company report.
Recent activity
Dbott Biotec Private Limited has 6 board changes on record since 2012: 3 appointments and 3 cessations. The latest: Kamlesh Kumar ceased to be Director on 15 Feb 2018.
Frequently asked questions
Dbott Biotec is an active private limited company based in New Delhi, Delhi, India. The company works in chemical products, within the chemicals industry. It was incorporated on 21 September 2012 (14+ years old) and is registered under CIN U24233DL2012PTC242650.
Dbott Biotec has 3 current directors:
- Nirmal Kumar - Director
- Rajesh Kumar Singh - Director
- Ranjay Kumar - Director
The latest financial statements of Dbott Biotec on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dbott Biotec is 10AAECD4209P1ZS, registered in Bihar.
The CIN (Corporate Identification Number) of Dbott Biotec is U24233DL2012PTC242650. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dbott Biotec was incorporated on 21 September 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
Kamlesh Kumar ceased to be Director on 15 Feb 2018. Mukesh Kumar ceased to be Director on 05 Dec 2015. Rangnath Sharma ceased to be Director on 05 Dec 2015. Dbott Biotec has 6 board changes on record in total.
The registered office of Dbott Biotec is at House No – S – 124 Road No – 4 West Vinod Nagar, New Delhi, Delhi, India – 110092.
Dbott Biotec operates in the chemicals industry, in the chemical products segment.
The compliance status of Dbott Biotec is compliant as of 25 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
